News — BioClavis

Home
Technology

BioClavis Technology
High-throughput transcriptomics with TempO-Seq

Explore the assay chemistry, workflow, technical resources, publications and platform advantages.
View Technology

Technology Overview
TempO-Seq TempO-Seq Workflow TempO-Span

Technical Resources
Resources Publications FAQs Detector Oligo Design Limitations of RNA-seq Patents
Products

BioClavis Products
TempO-Seq assays, panels & analysis tools

Browse BioClavis product pages, clinically relevant sample formats, data tools and partner programmes.
View Products

Platforms & Panels
Panels TempO-Seq TempO-LINC TempO-Seq miRNA

Samples & Data
FFPE TempO-Seq Blood Spot TempO-Seq Portal Assays

Partners & Programmes
Our Distributors Collaborations Request Information
Services

BioClavis Services
From study design to biological insight

Access transcriptomics services for pharma, academic and clinical programmes with downstream bioinformatics support.
Explore Services

Research Services
Pharma Toxicology & Safety Academic Research Clinical Research

Analysis & Customer
Bioinformatics Services Customer Page Contact BioClavis
News
Conferences
About

About BioClavis
Company, community & careers

Learn about BioClavis, its global access, community work and opportunities to join the team.
Our Story

Company
Our Story Our Distributors

Community & Team
CSR Careers Contact BioClavis
Customer Page
FAQ's
Enquiries

Revolutionizing Cancer Care: BRECISE Project Pioneers Precision Oncology

Ayokunmi AkanleMay 19, 2025

BioClavis advances single-cell genomics with launch of tempo-linc platform

Ayokunmi AkanleFebruary 26, 2024

BioClavis partner on newly launched RISK-HUNT3R project

Guest UserJune 24, 2021

BioClavis Win Rising Stars: High Growth Award at the 2021 Scotland's Life Sciences Awards

Guest UserMarch 25, 2021

Affordable and accurate barcode-style COVID-19 test could help open up workplaces by reassuring employers and staff

Guest UserDecember 19, 2020